An Open-label Extension Study Following a Double-blind, Randomized, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Pediatric Partial Onset Seizures
Latest Information Update: 14 Oct 2021
At a glance
- Drugs Zonisamide (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Registrational
- Acronyms CATZ Extension
- Sponsors Eisai Inc
- 25 Jun 2013 Results presented at the 30th International Epilepsy Congress.
- 25 Jun 2013 Results presented at the 30th International Epilepsy Congress.
- 19 Feb 2013 New trial record